NO306952B1 - Rensede heparinfraksjoner, fremgangsmåte ved fremstilling derav og farmasoeytiske blandinger som inneholder dem - Google Patents

Rensede heparinfraksjoner, fremgangsmåte ved fremstilling derav og farmasoeytiske blandinger som inneholder dem

Info

Publication number
NO306952B1
NO306952B1 NO941686A NO941686A NO306952B1 NO 306952 B1 NO306952 B1 NO 306952B1 NO 941686 A NO941686 A NO 941686A NO 941686 A NO941686 A NO 941686A NO 306952 B1 NO306952 B1 NO 306952B1
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
heparin fractions
purified heparin
Prior art date
Application number
NO941686A
Other languages
English (en)
Other versions
NO941686D0 (no
NO941686L (no
Inventor
Jean-Francois Branellec
Jose Espejo
Philippe Picart
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9446915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO306952(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Choay Sa filed Critical Choay Sa
Publication of NO941686D0 publication Critical patent/NO941686D0/no
Publication of NO941686L publication Critical patent/NO941686L/no
Publication of NO306952B1 publication Critical patent/NO306952B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO941686A 1993-05-07 1994-05-06 Rensede heparinfraksjoner, fremgangsmåte ved fremstilling derav og farmasoeytiske blandinger som inneholder dem NO306952B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305534A FR2704861B1 (fr) 1993-05-07 1993-05-07 Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.

Publications (3)

Publication Number Publication Date
NO941686D0 NO941686D0 (no) 1994-05-06
NO941686L NO941686L (no) 1994-11-08
NO306952B1 true NO306952B1 (no) 2000-01-17

Family

ID=9446915

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941686A NO306952B1 (no) 1993-05-07 1994-05-06 Rensede heparinfraksjoner, fremgangsmåte ved fremstilling derav og farmasoeytiske blandinger som inneholder dem

Country Status (26)

Country Link
US (1) US5599801A (no)
EP (1) EP0623629B1 (no)
JP (1) JP3529835B2 (no)
KR (1) KR100328095B1 (no)
CN (1) CN1066155C (no)
AT (1) ATE141618T1 (no)
AU (1) AU672291B2 (no)
BR (1) BR9401920A (no)
CA (1) CA2122930C (no)
CZ (1) CZ287889B6 (no)
DE (1) DE69400385T2 (no)
DK (1) DK0623629T3 (no)
ES (1) ES2093494T3 (no)
FI (1) FI107388B (no)
FR (1) FR2704861B1 (no)
GR (1) GR3021648T3 (no)
HK (1) HK1007432A1 (no)
HU (1) HU221595B (no)
IL (1) IL109587A (no)
MY (1) MY110862A (no)
NO (1) NO306952B1 (no)
NZ (1) NZ260460A (no)
PL (1) PL178294B1 (no)
RU (1) RU2133253C1 (no)
TW (1) TW438812B (no)
ZA (1) ZA943152B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
CA2235223A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
JP2003527822A (ja) * 1998-08-27 2003-09-24 マサチューセッツ インスティテュート オブ テクノロジー ヘパリナーゼｉおよびｉｉ由来の合理的に設計されたヘパリナーゼ
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
CA2643162C (en) * 1999-04-23 2018-01-02 Massachusetts Institute Of Technology Polymer identification, compositional analysis and sequencing, based on property comparison
CA2402160C (en) * 2000-03-08 2012-02-14 Massachusetts Institute Of Technology Heparinase iii and uses thereof
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
ATE426805T1 (de) * 2000-09-12 2009-04-15 Massachusetts Inst Technology Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
CA2423469A1 (en) * 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US20050027117A1 (en) * 2000-12-18 2005-02-03 Pasqua Oreste Anticoagulant and antithrombotic LMW-glycosaminoglycans derived from K5 polysaccharide and process for their preparation
JP2002293804A (ja) * 2001-03-28 2002-10-09 Itoham Foods Inc 低分子量ヘパリンの製造法
EP2402753A1 (en) 2002-03-11 2012-01-04 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ITMO20040199A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Procedimento per la purificazione da gruppi e n no rsidui di eparine a basso peso molecolare ottentite tramite nitrosazione.
JP2006291028A (ja) * 2005-04-11 2006-10-26 Q P Corp 低分子ヘパリンまたはその塩、ならびにその製造方法
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
ES2817779T3 (es) * 2010-01-19 2021-04-08 Momenta Pharmaceuticals Inc Evaluación de preparaciones de heparina
CA2811186C (en) * 2010-09-14 2018-12-04 Michio Muguruma High purity heparin and production method therefor
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102633905B (zh) * 2011-04-11 2014-10-08 南通天龙畜产品有限公司 一种肝素钠中不被亚硝酸降解且在肝素钠保留时间附近出峰的物质的去除方法
CN104045744B (zh) * 2014-06-26 2016-01-06 常州千红生化制药股份有限公司 达肝素钠的制备方法
CN104098716B (zh) * 2014-07-16 2015-04-22 南京健友生化制药股份有限公司 一种达肝素钠精品的生产方法
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN105294885A (zh) * 2015-11-23 2016-02-03 山东大学 一种新来源亚硝酸降解低分子肝素的制备方法
EP3740513B1 (en) * 2018-02-14 2022-06-22 Biological E Limited Improved process for the preparation of dalteparin sodium
RU186728U1 (ru) * 2018-10-19 2019-01-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "МИРЭА - Российский технологический университет" Лабораторное устройство для отмывки порошковых продуктов химических реакций от посторонних примесей
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
CN114616340A (zh) 2019-07-09 2022-06-10 奥普蒂姆维亚有限公司 合成抗凝血多糖的方法
CN110845641A (zh) * 2019-11-07 2020-02-28 中国药科大学 一种肝素寡糖及其在制备抗血管生成药物中的应用
CN110787489A (zh) * 2019-11-20 2020-02-14 江苏千牧生物科技股份有限公司 一种肝素钠加工使用的分离装置及加工的工艺
CN115304688A (zh) * 2022-08-25 2022-11-08 湖北亿诺瑞生物制药有限公司 一种达肝素钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4438261A (en) * 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
US5094815A (en) * 1988-05-18 1992-03-10 Cornell Research Foundation, Inc. Photolytic interface for HPLC-chemiluminescence detection of non volatile N-nitroso compounds
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia

Also Published As

Publication number Publication date
HK1007432A1 (en) 1999-04-09
MY110862A (en) 1999-05-31
IL109587A (en) 1997-04-15
TW438812B (en) 2001-06-07
NO941686D0 (no) 1994-05-06
HU9401446D0 (en) 1994-08-29
ES2093494T3 (es) 1996-12-16
AU672291B2 (en) 1996-09-26
CN1096034A (zh) 1994-12-07
IL109587A0 (en) 1994-08-26
CZ287889B6 (cs) 2001-03-14
EP0623629A1 (fr) 1994-11-09
FR2704861A1 (fr) 1994-11-10
HUT70553A (en) 1995-10-30
EP0623629B1 (fr) 1996-08-21
ZA943152B (en) 1995-01-09
FI942095A0 (fi) 1994-05-06
CA2122930A1 (en) 1994-11-08
ATE141618T1 (de) 1996-09-15
RU2133253C1 (ru) 1999-07-20
RU94015595A (ru) 1996-09-27
CA2122930C (en) 2000-10-24
PL178294B1 (pl) 2000-04-28
US5599801A (en) 1997-02-04
JP3529835B2 (ja) 2004-05-24
JPH07126302A (ja) 1995-05-16
AU6191294A (en) 1994-11-10
DE69400385D1 (de) 1996-09-26
DK0623629T3 (da) 1996-12-23
GR3021648T3 (en) 1997-02-28
CZ113294A3 (en) 1994-12-15
CN1066155C (zh) 2001-05-23
NO941686L (no) 1994-11-08
BR9401920A (pt) 1994-11-29
DE69400385T2 (de) 1996-12-19
FR2704861B1 (fr) 1995-07-28
NZ260460A (en) 1996-02-27
FI942095A (fi) 1994-11-08
KR100328095B1 (ko) 2002-06-20
HU221595B (hu) 2002-11-28
FI107388B (fi) 2001-07-31

Similar Documents

Publication Publication Date Title
NO941686L (no) Rensede heparinfraksjoner, fremgangsmåte ved fremstilling derav og farmasöytiske blandinger som inneholder dem
ES2081458T3 (es) Composicion de pintura.
DE69315724D1 (de) Polysaccharidderivate von Heparin, Heparansulfate, ihre Fraktionen und Fragmente, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, welche diese enthalten
GR3034985T3 (en) Cinnamic acid derivatives, photocrosslinkable cinnamic acid-polymer derivative and crosslinked cinnamic acid polymer derivatives
PT98481A (pt) Processo para a preparacao de clatratos de peroxiacidos
ATE121949T1 (de) 5,10-methylentetrahydrofolsäure-cyclodextrin- einschlussverbindungen.
IT8468235A1 (it) Nuovi derivati di 3-benzilidene-canfora, procedimento per la loro preparazione e loro impiego come agenti protettivi contro i raggi UV e come farmaci.
BR0006082A (pt) Fenol-novolacs com propriedades ópticas aperfeiçoadas
IT1269961B (it) Processo per la produzione di derivati orto-isopropil-fenoli
NO975466L (no) Amorf, farget plate av en krystalliserbar termoplast
ITMI931019A0 (it) Derivati del cicloeptimmidazolo, metodo per la loro produzione e agenti terapeutici contenenti questi composti
IT1256236B (it) Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
ATA252892A (de) Benzofuranylimidazolderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATE128977T1 (de) 1,4-benzodioxanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
IT8921578A0 (it) Derivati imidazolici 1,5 disostituiti e processo per la loro preparazione.
ITMI920437A1 (it) Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
AU1162592A (en) Low-molecular sulphated poly-beta -2,6-fructofuranosanes and their use in the treatment of degenerative articular ailments
PT89500A (pt) Processo para a preparacao de derivados de tetra-hidropiridina e de composicoes farmaceuticas que os contem
ITMI930421A0 (it) Derivati del benzofurano e loro uso come stabilizzanti verso le radiazioni uv
ITMI913034A1 (it) Metodo per il trattamento chimico di tutte le sostanze organiche con un prodotto atto ad eliminare in modo rapido gli odori da esse emanati e per l'impiego del composto risultante come fertilizzante
ITRM920631A1 (it) Processo chimico industriale e relativo impianto per la decomposizione e demilitarizzazione della miscela di aggressivi chimici: iprite e fenildicloro arsina.
MY129219A (en) Stabilization of lacquers
ATE105284T1 (de) Pyridazin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.

Legal Events

Date Code Title Description
MK1K Patent expired